Related references
Note: Only part of the references are listed.Neuroprotective Effects of Progesterone in Chronic Experimental Autoimmune Encephalomyelitis
S. Giatti et al.
JOURNAL OF NEUROENDOCRINOLOGY (2012)
Axon-glia synapses are highly vulnerable to white matter injury in the developing brain
Yan Shen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Impaired neurosteroid synthesis in multiple sclerosis
Farshid Noorbakhsh et al.
BRAIN (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF
Mohamed El-Behi et al.
NATURE IMMUNOLOGY (2011)
Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis
M. A. Yates et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
NG2 Glia Generate New Oligodendrocytes But Few Astrocytes in a Murine Experimental Autoimmune Encephalomyelitis Model of Demyelinating Disease
Richa B. Tripathi et al.
JOURNAL OF NEUROSCIENCE (2010)
Progesterone attenuates neurological behavioral deficits of experimental autoimmune encephalomyelitis through remyelination with nucleus-sublocalized Olig1 protein
Hong-jun Yu et al.
NEUROSCIENCE LETTERS (2010)
Three-Dimensional Structure of TspO by Electron Cryomicroscopy of Helical Crystals
Vladimir M. Korkhov et al.
STRUCTURE (2010)
Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography
Anne Roivainen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Translocator protein (18 kDa) TSPO: An emerging therapeutic target in neurotrauma
Vassilios Papadopoulos et al.
EXPERIMENTAL NEUROLOGY (2009)
Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain
M. Cosenza-Nashat et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2009)
CELLULAR ORGANIZATION OF THE CENTRAL CANAL EPENDYMAL ZONE, A NICHE OF LATENT NEURAL STEM CELLS IN THE ADULT MAMMALIAN SPINAL CORD
L. K. Hamilton et al.
NEUROSCIENCE (2009)
Translocator protein (TSPO 18 kDa) is expressed by neural stem and neuronal precursor cells
Balazs Varga et al.
NEUROSCIENCE LETTERS (2009)
Increased Binding of Peripheral Benzodiazepine Receptor in Alzheimer's Disease Measured by Positron Emission Tomography with [11C]DAA1106
Furnihiko Yasuno et al.
BIOLOGICAL PSYCHIATRY (2008)
Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone
Stefan M. Gold et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study
Paul Edison et al.
NEUROBIOLOGY OF DISEASE (2008)
Etifoxine improves peripheral nerve regeneration and functional recovery
Christelle Girard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats
Rajesh R. Ugale et al.
BRAIN RESEARCH (2007)
Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival
Eugene Vlodavsky et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain
M Verleye et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum
JK Ryu et al.
NEUROBIOLOGY OF DISEASE (2005)
Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity
S Veiga et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Microglial activation and dopamine terminal loss in early Parkinson's disease
Y Ouchi et al.
ANNALS OF NEUROLOGY (2005)
Evolution of microglial activation in patients after ischemic stroke:: a [11C](R)-PK11195 PET study
A Gerhard et al.
NEUROIMAGE (2005)
Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study
J Versijpt et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures
AM Ghoumari et al.
NEUROSCIENCE (2005)
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis:: an [11C](R)-PK11195 positron emission tomography study
MR Turner et al.
NEUROBIOLOGY OF DISEASE (2004)
In vivo detection of microglial activation in frontotemporal dementia
A Cagnin et al.
ANNALS OF NEUROLOGY (2004)
Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum
AM Ghoumari et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol
SS Soldan et al.
JOURNAL OF IMMUNOLOGY (2003)
Inhibition of lipopolysaccharide-induced cyclooxygenase-2, tumor necrosis factor-α and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195
HB Choi et al.
JOURNAL OF NEUROCHEMISTRY (2002)
SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair
B Ferzaz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine
R Schlichter et al.
NEUROPHARMACOLOGY (2000)
Share Paper
